Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Died Vice-President of Lukoil Vitaly Robertus

3/14/24 LKOH

Severstal started construction of a complex in Cherepovets

3/13/24 CHMF

Drones damaged installations of Ryazan NPK

3/13/24 ROSN

JSFC Sistema will develop hydrogen technologies in the SEZ of Mordovia

3/13/24 AFKS

Yandex.Market began testing Roboruka

3/13/24 YNDX

X5 Retail Group starts robotization of distribution centers

3/13/24 X5

Severstal does not rule out more than 100% FCF

3/13/24 CHMF

Drone attack on Lukoil refinery reduced its capacity by 50%

3/13/24 LKOH

Tinkoff Investments launches Pre-IPO platform

3/13/24 T

M.Video-Eldorado to open stores in new territories

3/13/24 MVID